|Day Low/High||5.93 / 6.00|
|52 Wk Low/High||3.07 / 13.80|
Versartis, Adamas and DBV Technologies were among the biotech movers ahead of the market open on Dec. 1.
The Menlo Park, Calif.-based firm on Thursday reported third-quarter results and said it has hired Cowen to help with evaluating potential transactions.
The FDA on Thursday issued a safety announcement saying Intercept's liver disease treatment Ocaliva is being dosed incorrectly in some patients.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Versartis Inc , where a total volume of 13,527 contracts has been traded thus far today, a contract volume which is representative of approximately 1.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 207.1% of VSAR's average daily trading volume over the past month, of 653,070 shares.
Investors in Versartis Inc saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VSAR options chain for the new November 17th contracts and identified one put and one call contract of particular interest.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Versartis Inc , where a total volume of 1,652 contracts has been traded thus far today, a contract volume which is representative of approximately 165,200 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 56.8% of VSAR's average daily trading volume over the past month, of 291,100 shares.
Confirms Phase 3 Data Expected Late September
Investors eyeing a purchase of Versartis Inc shares, but tentative about paying the going market price of $16.45/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $12.50 strike, which has a bid at the time of this writing of $2.90.
Levi & Korsinsky, LLP announces it has commenced an investigation of Versartis Inc.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Insiders at these companies have been scooping up shares in their own organizations lately.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.